nodes	percent_of_prediction	percent_of_DWPC	metapath
Leflunomide—rheumatoid arthritis—psoriatic arthritis	0.863	1	CtDrD
Leflunomide—ABCG2—Dexamethasone—psoriatic arthritis	0.0106	0.46	CbGbCtD
Leflunomide—ABCG2—Methotrexate—psoriatic arthritis	0.00849	0.369	CbGbCtD
Leflunomide—CYP2C9—Dexamethasone—psoriatic arthritis	0.00392	0.171	CbGbCtD
Leflunomide—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.000111	0.000978	CcSEcCtD
Leflunomide—Dry mouth—Triamcinolone—psoriatic arthritis	0.000111	0.000972	CcSEcCtD
Leflunomide—Renal failure—Methotrexate—psoriatic arthritis	0.000111	0.00097	CcSEcCtD
Leflunomide—Angioedema—Dexamethasone—psoriatic arthritis	0.00011	0.000968	CcSEcCtD
Leflunomide—Angioedema—Betamethasone—psoriatic arthritis	0.00011	0.000968	CcSEcCtD
Leflunomide—Stomatitis—Methotrexate—psoriatic arthritis	0.00011	0.000962	CcSEcCtD
Leflunomide—Conjunctivitis—Methotrexate—psoriatic arthritis	0.000109	0.000959	CcSEcCtD
Leflunomide—Immune system disorder—Prednisone—psoriatic arthritis	0.000109	0.000957	CcSEcCtD
Leflunomide—Malaise—Dexamethasone—psoriatic arthritis	0.000109	0.000955	CcSEcCtD
Leflunomide—Malaise—Betamethasone—psoriatic arthritis	0.000109	0.000955	CcSEcCtD
Leflunomide—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000109	0.000953	CcSEcCtD
Leflunomide—Vertigo—Betamethasone—psoriatic arthritis	0.000108	0.000952	CcSEcCtD
Leflunomide—Vertigo—Dexamethasone—psoriatic arthritis	0.000108	0.000952	CcSEcCtD
Leflunomide—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000108	0.000951	CcSEcCtD
Leflunomide—Arrhythmia—Prednisone—psoriatic arthritis	0.000108	0.000947	CcSEcCtD
Leflunomide—Infection—Triamcinolone—psoriatic arthritis	0.000108	0.000947	CcSEcCtD
Leflunomide—Infection—Methylprednisolone—psoriatic arthritis	0.000108	0.000944	CcSEcCtD
Leflunomide—Haematuria—Methotrexate—psoriatic arthritis	0.000107	0.000941	CcSEcCtD
Leflunomide—Insomnia—Prednisolone—psoriatic arthritis	0.000107	0.000937	CcSEcCtD
Leflunomide—Alopecia—Prednisone—psoriatic arthritis	0.000107	0.000936	CcSEcCtD
Leflunomide—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000106	0.000933	CcSEcCtD
Leflunomide—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000106	0.000932	CcSEcCtD
Leflunomide—Epistaxis—Methotrexate—psoriatic arthritis	0.000106	0.000931	CcSEcCtD
Leflunomide—Paraesthesia—Prednisolone—psoriatic arthritis	0.000106	0.00093	CcSEcCtD
Leflunomide—Tachycardia—Triamcinolone—psoriatic arthritis	0.000106	0.00093	CcSEcCtD
Leflunomide—Mental disorder—Prednisone—psoriatic arthritis	0.000106	0.000928	CcSEcCtD
Leflunomide—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000106	0.000928	CcSEcCtD
Leflunomide—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000105	0.000923	CcSEcCtD
Leflunomide—Malnutrition—Prednisone—psoriatic arthritis	0.000105	0.000922	CcSEcCtD
Leflunomide—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000105	0.000921	CcSEcCtD
Leflunomide—Agranulocytosis—Methotrexate—psoriatic arthritis	0.000105	0.000921	CcSEcCtD
Leflunomide—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000105	0.000919	CcSEcCtD
Leflunomide—Hypertension—Dexamethasone—psoriatic arthritis	0.000104	0.000915	CcSEcCtD
Leflunomide—Hypertension—Betamethasone—psoriatic arthritis	0.000104	0.000915	CcSEcCtD
Leflunomide—Myalgia—Dexamethasone—psoriatic arthritis	0.000103	0.000902	CcSEcCtD
Leflunomide—Myalgia—Betamethasone—psoriatic arthritis	0.000103	0.000902	CcSEcCtD
Leflunomide—Anxiety—Betamethasone—psoriatic arthritis	0.000102	0.000899	CcSEcCtD
Leflunomide—Anxiety—Dexamethasone—psoriatic arthritis	0.000102	0.000899	CcSEcCtD
Leflunomide—Discomfort—Dexamethasone—psoriatic arthritis	0.000102	0.000891	CcSEcCtD
Leflunomide—Discomfort—Betamethasone—psoriatic arthritis	0.000102	0.000891	CcSEcCtD
Leflunomide—Haemoglobin—Methotrexate—psoriatic arthritis	0.000101	0.00089	CcSEcCtD
Leflunomide—Hypotension—Methylprednisolone—psoriatic arthritis	0.000101	0.000888	CcSEcCtD
Leflunomide—Pain—Prednisolone—psoriatic arthritis	0.000101	0.000886	CcSEcCtD
Leflunomide—Haemorrhage—Methotrexate—psoriatic arthritis	0.000101	0.000886	CcSEcCtD
Leflunomide—Hepatitis—Methotrexate—psoriatic arthritis	0.000101	0.000886	CcSEcCtD
Leflunomide—Pharyngitis—Methotrexate—psoriatic arthritis	0.0001	0.000879	CcSEcCtD
Leflunomide—Urinary tract disorder—Methotrexate—psoriatic arthritis	9.97e-05	0.000875	CcSEcCtD
Leflunomide—Vision blurred—Prednisone—psoriatic arthritis	9.91e-05	0.000869	CcSEcCtD
Leflunomide—Urethral disorder—Methotrexate—psoriatic arthritis	9.9e-05	0.000868	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	9.9e-05	0.000868	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	9.87e-05	0.000866	CcSEcCtD
Leflunomide—Anaphylactic shock—Betamethasone—psoriatic arthritis	9.85e-05	0.000865	CcSEcCtD
Leflunomide—Anaphylactic shock—Dexamethasone—psoriatic arthritis	9.85e-05	0.000865	CcSEcCtD
Leflunomide—Insomnia—Triamcinolone—psoriatic arthritis	9.82e-05	0.000862	CcSEcCtD
Leflunomide—Insomnia—Methylprednisolone—psoriatic arthritis	9.8e-05	0.00086	CcSEcCtD
Leflunomide—Infection—Dexamethasone—psoriatic arthritis	9.79e-05	0.000859	CcSEcCtD
Leflunomide—Infection—Betamethasone—psoriatic arthritis	9.79e-05	0.000859	CcSEcCtD
Leflunomide—Ill-defined disorder—Prednisone—psoriatic arthritis	9.76e-05	0.000856	CcSEcCtD
Leflunomide—Paraesthesia—Triamcinolone—psoriatic arthritis	9.75e-05	0.000856	CcSEcCtD
Leflunomide—Feeling abnormal—Prednisolone—psoriatic arthritis	9.73e-05	0.000854	CcSEcCtD
Leflunomide—Paraesthesia—Methylprednisolone—psoriatic arthritis	9.73e-05	0.000854	CcSEcCtD
Leflunomide—Anaemia—Prednisone—psoriatic arthritis	9.72e-05	0.000853	CcSEcCtD
Leflunomide—Dyspnoea—Triamcinolone—psoriatic arthritis	9.68e-05	0.000849	CcSEcCtD
Leflunomide—Nervous system disorder—Betamethasone—psoriatic arthritis	9.66e-05	0.000848	CcSEcCtD
Leflunomide—Nervous system disorder—Dexamethasone—psoriatic arthritis	9.66e-05	0.000848	CcSEcCtD
Leflunomide—Thrombocytopenia—Dexamethasone—psoriatic arthritis	9.65e-05	0.000846	CcSEcCtD
Leflunomide—Thrombocytopenia—Betamethasone—psoriatic arthritis	9.65e-05	0.000846	CcSEcCtD
Leflunomide—Tachycardia—Betamethasone—psoriatic arthritis	9.62e-05	0.000844	CcSEcCtD
Leflunomide—Tachycardia—Dexamethasone—psoriatic arthritis	9.62e-05	0.000844	CcSEcCtD
Leflunomide—Angioedema—Prednisone—psoriatic arthritis	9.61e-05	0.000843	CcSEcCtD
Leflunomide—Dyspepsia—Triamcinolone—psoriatic arthritis	9.56e-05	0.000839	CcSEcCtD
Leflunomide—Erythema multiforme—Methotrexate—psoriatic arthritis	9.55e-05	0.000837	CcSEcCtD
Leflunomide—Dyspepsia—Methylprednisolone—psoriatic arthritis	9.54e-05	0.000837	CcSEcCtD
Leflunomide—Hyperhidrosis—Dexamethasone—psoriatic arthritis	9.53e-05	0.000836	CcSEcCtD
Leflunomide—Hyperhidrosis—Betamethasone—psoriatic arthritis	9.53e-05	0.000836	CcSEcCtD
Leflunomide—Malaise—Prednisone—psoriatic arthritis	9.48e-05	0.000832	CcSEcCtD
Leflunomide—Vertigo—Prednisone—psoriatic arthritis	9.45e-05	0.000829	CcSEcCtD
Leflunomide—Eye disorder—Methotrexate—psoriatic arthritis	9.43e-05	0.000828	CcSEcCtD
Leflunomide—Anorexia—Betamethasone—psoriatic arthritis	9.39e-05	0.000824	CcSEcCtD
Leflunomide—Anorexia—Dexamethasone—psoriatic arthritis	9.39e-05	0.000824	CcSEcCtD
Leflunomide—Urticaria—Prednisolone—psoriatic arthritis	9.38e-05	0.000823	CcSEcCtD
Leflunomide—Cardiac disorder—Methotrexate—psoriatic arthritis	9.37e-05	0.000822	CcSEcCtD
Leflunomide—Fatigue—Triamcinolone—psoriatic arthritis	9.36e-05	0.000821	CcSEcCtD
Leflunomide—Fatigue—Methylprednisolone—psoriatic arthritis	9.34e-05	0.00082	CcSEcCtD
Leflunomide—Pain—Triamcinolone—psoriatic arthritis	9.29e-05	0.000815	CcSEcCtD
Leflunomide—Hypotension—Dexamethasone—psoriatic arthritis	9.21e-05	0.000808	CcSEcCtD
Leflunomide—Hypotension—Betamethasone—psoriatic arthritis	9.21e-05	0.000808	CcSEcCtD
Leflunomide—Immune system disorder—Methotrexate—psoriatic arthritis	9.12e-05	0.0008	CcSEcCtD
Leflunomide—Mediastinal disorder—Methotrexate—psoriatic arthritis	9.1e-05	0.000798	CcSEcCtD
Leflunomide—Hypertension—Prednisone—psoriatic arthritis	9.08e-05	0.000796	CcSEcCtD
Leflunomide—Chills—Methotrexate—psoriatic arthritis	9.06e-05	0.000795	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	8.98e-05	0.000788	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	8.98e-05	0.000788	CcSEcCtD
Leflunomide—Arthralgia—Prednisone—psoriatic arthritis	8.95e-05	0.000785	CcSEcCtD
Leflunomide—Myalgia—Prednisone—psoriatic arthritis	8.95e-05	0.000785	CcSEcCtD
Leflunomide—Feeling abnormal—Triamcinolone—psoriatic arthritis	8.95e-05	0.000785	CcSEcCtD
Leflunomide—Feeling abnormal—Methylprednisolone—psoriatic arthritis	8.93e-05	0.000783	CcSEcCtD
Leflunomide—Anxiety—Prednisone—psoriatic arthritis	8.92e-05	0.000783	CcSEcCtD
Leflunomide—Alopecia—Methotrexate—psoriatic arthritis	8.92e-05	0.000783	CcSEcCtD
Leflunomide—Insomnia—Dexamethasone—psoriatic arthritis	8.91e-05	0.000782	CcSEcCtD
Leflunomide—Insomnia—Betamethasone—psoriatic arthritis	8.91e-05	0.000782	CcSEcCtD
Leflunomide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	8.89e-05	0.00078	CcSEcCtD
Leflunomide—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	8.86e-05	0.000777	CcSEcCtD
Leflunomide—Paraesthesia—Dexamethasone—psoriatic arthritis	8.85e-05	0.000776	CcSEcCtD
Leflunomide—Paraesthesia—Betamethasone—psoriatic arthritis	8.85e-05	0.000776	CcSEcCtD
Leflunomide—Discomfort—Prednisone—psoriatic arthritis	8.85e-05	0.000776	CcSEcCtD
Leflunomide—Mental disorder—Methotrexate—psoriatic arthritis	8.84e-05	0.000776	CcSEcCtD
Leflunomide—Malnutrition—Methotrexate—psoriatic arthritis	8.79e-05	0.000771	CcSEcCtD
Leflunomide—Hypersensitivity—Prednisolone—psoriatic arthritis	8.7e-05	0.000763	CcSEcCtD
Leflunomide—Dyspepsia—Dexamethasone—psoriatic arthritis	8.67e-05	0.000761	CcSEcCtD
Leflunomide—Dyspepsia—Betamethasone—psoriatic arthritis	8.67e-05	0.000761	CcSEcCtD
Leflunomide—Urticaria—Triamcinolone—psoriatic arthritis	8.63e-05	0.000757	CcSEcCtD
Leflunomide—Urticaria—Methylprednisolone—psoriatic arthritis	8.61e-05	0.000755	CcSEcCtD
Leflunomide—Dysgeusia—Methotrexate—psoriatic arthritis	8.61e-05	0.000755	CcSEcCtD
Leflunomide—Body temperature increased—Triamcinolone—psoriatic arthritis	8.59e-05	0.000753	CcSEcCtD
Leflunomide—Anaphylactic shock—Prednisone—psoriatic arthritis	8.58e-05	0.000753	CcSEcCtD
Leflunomide—Abdominal pain—Methylprednisolone—psoriatic arthritis	8.57e-05	0.000752	CcSEcCtD
Leflunomide—Decreased appetite—Dexamethasone—psoriatic arthritis	8.57e-05	0.000752	CcSEcCtD
Leflunomide—Decreased appetite—Betamethasone—psoriatic arthritis	8.57e-05	0.000752	CcSEcCtD
Leflunomide—Infection—Prednisone—psoriatic arthritis	8.53e-05	0.000748	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	8.51e-05	0.000746	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	8.51e-05	0.000746	CcSEcCtD
Leflunomide—Back pain—Methotrexate—psoriatic arthritis	8.5e-05	0.000746	CcSEcCtD
Leflunomide—Fatigue—Dexamethasone—psoriatic arthritis	8.5e-05	0.000745	CcSEcCtD
Leflunomide—Fatigue—Betamethasone—psoriatic arthritis	8.5e-05	0.000745	CcSEcCtD
Leflunomide—Pain—Betamethasone—psoriatic arthritis	8.43e-05	0.000739	CcSEcCtD
Leflunomide—Pain—Dexamethasone—psoriatic arthritis	8.43e-05	0.000739	CcSEcCtD
Leflunomide—Nervous system disorder—Prednisone—psoriatic arthritis	8.42e-05	0.000738	CcSEcCtD
Leflunomide—Tachycardia—Prednisone—psoriatic arthritis	8.38e-05	0.000735	CcSEcCtD
Leflunomide—Skin disorder—Prednisone—psoriatic arthritis	8.34e-05	0.000731	CcSEcCtD
Leflunomide—Hyperhidrosis—Prednisone—psoriatic arthritis	8.3e-05	0.000728	CcSEcCtD
Leflunomide—Vision blurred—Methotrexate—psoriatic arthritis	8.28e-05	0.000727	CcSEcCtD
Leflunomide—Anorexia—Prednisone—psoriatic arthritis	8.18e-05	0.000718	CcSEcCtD
Leflunomide—Ill-defined disorder—Methotrexate—psoriatic arthritis	8.15e-05	0.000715	CcSEcCtD
Leflunomide—Anaemia—Methotrexate—psoriatic arthritis	8.12e-05	0.000713	CcSEcCtD
Leflunomide—Feeling abnormal—Dexamethasone—psoriatic arthritis	8.12e-05	0.000712	CcSEcCtD
Leflunomide—Feeling abnormal—Betamethasone—psoriatic arthritis	8.12e-05	0.000712	CcSEcCtD
Leflunomide—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	8.06e-05	0.000707	CcSEcCtD
Leflunomide—Gastrointestinal pain—Betamethasone—psoriatic arthritis	8.06e-05	0.000707	CcSEcCtD
Leflunomide—Hypersensitivity—Triamcinolone—psoriatic arthritis	8e-05	0.000702	CcSEcCtD
Leflunomide—Hypersensitivity—Methylprednisolone—psoriatic arthritis	7.98e-05	0.0007	CcSEcCtD
Leflunomide—Malaise—Methotrexate—psoriatic arthritis	7.93e-05	0.000695	CcSEcCtD
Leflunomide—Vertigo—Methotrexate—psoriatic arthritis	7.9e-05	0.000693	CcSEcCtD
Leflunomide—Leukopenia—Methotrexate—psoriatic arthritis	7.87e-05	0.00069	CcSEcCtD
Leflunomide—Urticaria—Dexamethasone—psoriatic arthritis	7.83e-05	0.000687	CcSEcCtD
Leflunomide—Urticaria—Betamethasone—psoriatic arthritis	7.83e-05	0.000687	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	7.82e-05	0.000686	CcSEcCtD
Leflunomide—Dizziness—Prednisolone—psoriatic arthritis	7.81e-05	0.000685	CcSEcCtD
Leflunomide—Asthenia—Triamcinolone—psoriatic arthritis	7.79e-05	0.000684	CcSEcCtD
Leflunomide—Body temperature increased—Betamethasone—psoriatic arthritis	7.79e-05	0.000683	CcSEcCtD
Leflunomide—Abdominal pain—Betamethasone—psoriatic arthritis	7.79e-05	0.000683	CcSEcCtD
Leflunomide—Abdominal pain—Dexamethasone—psoriatic arthritis	7.79e-05	0.000683	CcSEcCtD
Leflunomide—Body temperature increased—Dexamethasone—psoriatic arthritis	7.79e-05	0.000683	CcSEcCtD
Leflunomide—Asthenia—Methylprednisolone—psoriatic arthritis	7.78e-05	0.000682	CcSEcCtD
Leflunomide—Insomnia—Prednisone—psoriatic arthritis	7.76e-05	0.000681	CcSEcCtD
Leflunomide—Paraesthesia—Prednisone—psoriatic arthritis	7.71e-05	0.000676	CcSEcCtD
Leflunomide—Pruritus—Triamcinolone—psoriatic arthritis	7.68e-05	0.000674	CcSEcCtD
Leflunomide—Cough—Methotrexate—psoriatic arthritis	7.67e-05	0.000673	CcSEcCtD
Leflunomide—Pruritus—Methylprednisolone—psoriatic arthritis	7.67e-05	0.000673	CcSEcCtD
Leflunomide—Dyspepsia—Prednisone—psoriatic arthritis	7.55e-05	0.000663	CcSEcCtD
Leflunomide—Arthralgia—Methotrexate—psoriatic arthritis	7.48e-05	0.000656	CcSEcCtD
Leflunomide—Myalgia—Methotrexate—psoriatic arthritis	7.48e-05	0.000656	CcSEcCtD
Leflunomide—Chest pain—Methotrexate—psoriatic arthritis	7.48e-05	0.000656	CcSEcCtD
Leflunomide—Decreased appetite—Prednisone—psoriatic arthritis	7.46e-05	0.000654	CcSEcCtD
Leflunomide—Rash—Prednisolone—psoriatic arthritis	7.45e-05	0.000653	CcSEcCtD
Leflunomide—Dermatitis—Prednisolone—psoriatic arthritis	7.44e-05	0.000653	CcSEcCtD
Leflunomide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	7.43e-05	0.000652	CcSEcCtD
Leflunomide—Diarrhoea—Methylprednisolone—psoriatic arthritis	7.41e-05	0.00065	CcSEcCtD
Leflunomide—Fatigue—Prednisone—psoriatic arthritis	7.4e-05	0.000649	CcSEcCtD
Leflunomide—Headache—Prednisolone—psoriatic arthritis	7.4e-05	0.000649	CcSEcCtD
Leflunomide—Discomfort—Methotrexate—psoriatic arthritis	7.39e-05	0.000648	CcSEcCtD
Leflunomide—Constipation—Prednisone—psoriatic arthritis	7.34e-05	0.000644	CcSEcCtD
Leflunomide—Dizziness—Triamcinolone—psoriatic arthritis	7.18e-05	0.00063	CcSEcCtD
Leflunomide—Anaphylactic shock—Methotrexate—psoriatic arthritis	7.17e-05	0.000629	CcSEcCtD
Leflunomide—Dizziness—Methylprednisolone—psoriatic arthritis	7.17e-05	0.000629	CcSEcCtD
Leflunomide—Infection—Methotrexate—psoriatic arthritis	7.13e-05	0.000625	CcSEcCtD
Leflunomide—Feeling abnormal—Prednisone—psoriatic arthritis	7.07e-05	0.00062	CcSEcCtD
Leflunomide—Asthenia—Dexamethasone—psoriatic arthritis	7.07e-05	0.00062	CcSEcCtD
Leflunomide—Asthenia—Betamethasone—psoriatic arthritis	7.07e-05	0.00062	CcSEcCtD
Leflunomide—Nervous system disorder—Methotrexate—psoriatic arthritis	7.03e-05	0.000617	CcSEcCtD
Leflunomide—Thrombocytopenia—Methotrexate—psoriatic arthritis	7.02e-05	0.000616	CcSEcCtD
Leflunomide—Gastrointestinal pain—Prednisone—psoriatic arthritis	7.02e-05	0.000616	CcSEcCtD
Leflunomide—Nausea—Prednisolone—psoriatic arthritis	7.02e-05	0.000615	CcSEcCtD
Leflunomide—Pruritus—Betamethasone—psoriatic arthritis	6.97e-05	0.000612	CcSEcCtD
Leflunomide—Pruritus—Dexamethasone—psoriatic arthritis	6.97e-05	0.000612	CcSEcCtD
Leflunomide—Skin disorder—Methotrexate—psoriatic arthritis	6.97e-05	0.000611	CcSEcCtD
Leflunomide—Hyperhidrosis—Methotrexate—psoriatic arthritis	6.93e-05	0.000608	CcSEcCtD
Leflunomide—Vomiting—Triamcinolone—psoriatic arthritis	6.91e-05	0.000606	CcSEcCtD
Leflunomide—Vomiting—Methylprednisolone—psoriatic arthritis	6.89e-05	0.000604	CcSEcCtD
Leflunomide—Rash—Triamcinolone—psoriatic arthritis	6.85e-05	0.000601	CcSEcCtD
Leflunomide—Dermatitis—Triamcinolone—psoriatic arthritis	6.84e-05	0.0006	CcSEcCtD
Leflunomide—Anorexia—Methotrexate—psoriatic arthritis	6.84e-05	0.0006	CcSEcCtD
Leflunomide—Rash—Methylprednisolone—psoriatic arthritis	6.83e-05	0.000599	CcSEcCtD
Leflunomide—Dermatitis—Methylprednisolone—psoriatic arthritis	6.83e-05	0.000599	CcSEcCtD
Leflunomide—Urticaria—Prednisone—psoriatic arthritis	6.82e-05	0.000598	CcSEcCtD
Leflunomide—Headache—Triamcinolone—psoriatic arthritis	6.8e-05	0.000597	CcSEcCtD
Leflunomide—Headache—Methylprednisolone—psoriatic arthritis	6.79e-05	0.000596	CcSEcCtD
Leflunomide—Abdominal pain—Prednisone—psoriatic arthritis	6.78e-05	0.000595	CcSEcCtD
Leflunomide—Body temperature increased—Prednisone—psoriatic arthritis	6.78e-05	0.000595	CcSEcCtD
Leflunomide—Diarrhoea—Dexamethasone—psoriatic arthritis	6.74e-05	0.000591	CcSEcCtD
Leflunomide—Diarrhoea—Betamethasone—psoriatic arthritis	6.74e-05	0.000591	CcSEcCtD
Leflunomide—Hypotension—Methotrexate—psoriatic arthritis	6.7e-05	0.000588	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	6.53e-05	0.000573	CcSEcCtD
Leflunomide—Dizziness—Dexamethasone—psoriatic arthritis	6.52e-05	0.000572	CcSEcCtD
Leflunomide—Dizziness—Betamethasone—psoriatic arthritis	6.52e-05	0.000572	CcSEcCtD
Leflunomide—Insomnia—Methotrexate—psoriatic arthritis	6.49e-05	0.000569	CcSEcCtD
Leflunomide—Nausea—Triamcinolone—psoriatic arthritis	6.45e-05	0.000566	CcSEcCtD
Leflunomide—Paraesthesia—Methotrexate—psoriatic arthritis	6.44e-05	0.000565	CcSEcCtD
Leflunomide—Nausea—Methylprednisolone—psoriatic arthritis	6.44e-05	0.000565	CcSEcCtD
Leflunomide—Dyspnoea—Methotrexate—psoriatic arthritis	6.39e-05	0.000561	CcSEcCtD
Leflunomide—Hypersensitivity—Prednisone—psoriatic arthritis	6.32e-05	0.000555	CcSEcCtD
Leflunomide—Dyspepsia—Methotrexate—psoriatic arthritis	6.31e-05	0.000554	CcSEcCtD
Leflunomide—Vomiting—Betamethasone—psoriatic arthritis	6.27e-05	0.00055	CcSEcCtD
Leflunomide—Vomiting—Dexamethasone—psoriatic arthritis	6.27e-05	0.00055	CcSEcCtD
Leflunomide—Decreased appetite—Methotrexate—psoriatic arthritis	6.24e-05	0.000547	CcSEcCtD
Leflunomide—Rash—Betamethasone—psoriatic arthritis	6.21e-05	0.000545	CcSEcCtD
Leflunomide—Rash—Dexamethasone—psoriatic arthritis	6.21e-05	0.000545	CcSEcCtD
Leflunomide—Dermatitis—Dexamethasone—psoriatic arthritis	6.21e-05	0.000545	CcSEcCtD
Leflunomide—Dermatitis—Betamethasone—psoriatic arthritis	6.21e-05	0.000545	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	6.19e-05	0.000543	CcSEcCtD
Leflunomide—Fatigue—Methotrexate—psoriatic arthritis	6.18e-05	0.000542	CcSEcCtD
Leflunomide—Headache—Dexamethasone—psoriatic arthritis	6.17e-05	0.000542	CcSEcCtD
Leflunomide—Headache—Betamethasone—psoriatic arthritis	6.17e-05	0.000542	CcSEcCtD
Leflunomide—Asthenia—Prednisone—psoriatic arthritis	6.16e-05	0.00054	CcSEcCtD
Leflunomide—Pain—Methotrexate—psoriatic arthritis	6.13e-05	0.000538	CcSEcCtD
Leflunomide—Pruritus—Prednisone—psoriatic arthritis	6.07e-05	0.000533	CcSEcCtD
Leflunomide—Feeling abnormal—Methotrexate—psoriatic arthritis	5.91e-05	0.000518	CcSEcCtD
Leflunomide—Diarrhoea—Prednisone—psoriatic arthritis	5.87e-05	0.000515	CcSEcCtD
Leflunomide—Gastrointestinal pain—Methotrexate—psoriatic arthritis	5.87e-05	0.000515	CcSEcCtD
Leflunomide—Nausea—Dexamethasone—psoriatic arthritis	5.85e-05	0.000514	CcSEcCtD
Leflunomide—Nausea—Betamethasone—psoriatic arthritis	5.85e-05	0.000514	CcSEcCtD
Leflunomide—Urticaria—Methotrexate—psoriatic arthritis	5.7e-05	0.0005	CcSEcCtD
Leflunomide—Dizziness—Prednisone—psoriatic arthritis	5.68e-05	0.000498	CcSEcCtD
Leflunomide—Abdominal pain—Methotrexate—psoriatic arthritis	5.67e-05	0.000497	CcSEcCtD
Leflunomide—Body temperature increased—Methotrexate—psoriatic arthritis	5.67e-05	0.000497	CcSEcCtD
Leflunomide—Vomiting—Prednisone—psoriatic arthritis	5.46e-05	0.000479	CcSEcCtD
Leflunomide—Rash—Prednisone—psoriatic arthritis	5.41e-05	0.000475	CcSEcCtD
Leflunomide—Dermatitis—Prednisone—psoriatic arthritis	5.41e-05	0.000474	CcSEcCtD
Leflunomide—Headache—Prednisone—psoriatic arthritis	5.38e-05	0.000472	CcSEcCtD
Leflunomide—Hypersensitivity—Methotrexate—psoriatic arthritis	5.28e-05	0.000464	CcSEcCtD
Leflunomide—Asthenia—Methotrexate—psoriatic arthritis	5.15e-05	0.000451	CcSEcCtD
Leflunomide—Nausea—Prednisone—psoriatic arthritis	5.1e-05	0.000447	CcSEcCtD
Leflunomide—Pruritus—Methotrexate—psoriatic arthritis	5.07e-05	0.000445	CcSEcCtD
Leflunomide—Diarrhoea—Methotrexate—psoriatic arthritis	4.91e-05	0.000431	CcSEcCtD
Leflunomide—Dizziness—Methotrexate—psoriatic arthritis	4.74e-05	0.000416	CcSEcCtD
Leflunomide—Vomiting—Methotrexate—psoriatic arthritis	4.56e-05	0.0004	CcSEcCtD
Leflunomide—Rash—Methotrexate—psoriatic arthritis	4.52e-05	0.000397	CcSEcCtD
Leflunomide—Dermatitis—Methotrexate—psoriatic arthritis	4.52e-05	0.000396	CcSEcCtD
Leflunomide—Headache—Methotrexate—psoriatic arthritis	4.49e-05	0.000394	CcSEcCtD
Leflunomide—Nausea—Methotrexate—psoriatic arthritis	4.26e-05	0.000374	CcSEcCtD
